CT.gov Geography-Scale Visibility
2026-03-29 | full-registry ct.gov audit | plots, figures, and e156 bundle
Series
Geography Dashboard

Geography scale maps onto a much more visible registry record

Older multi-site and multinational studies look far more visible than single-site trials, and the gap remains visible within major phases.

Site footprint
Country footprint
Full visibility
Within phase

Dashboard

Once site footprint is plotted, the registry stops looking flat and starts looking stratified by operational scale.

How to read the dashboard
Single-site no results
79.5%
Older single-site studies
20+ sites no results
31.7%
Large site-footprint studies
Phase III single-site
76.3%
Phase III baseline
Phase III 20+ sites
25.7%
Phase III large-footprint
Site footprint
SITE FOOTPRINT2-year no-results rate by recorded site footprintMissing80.9%Single-site79.5%2-4 sites69.3%5-19 sites56.0%20+ sites31.7%
Single-site and missing-location studies sit in the quietest part of the registry.
The 20-plus-site bucket looks very different because large operational footprints also carry much higher full-visibility rates.
Country footprint
COUNTRY FOOTPRINT2-year no-results rate by recorded country footprintMissing80.9%Single-country75.5%2-4 countries53.2%5-19 countries30.7%20+ countries11.7%
The multinational gradient is even steeper at the high end, with the 20-plus-country bucket far more visible than single-country studies.
Country footprint is a simpler public proxy for operational reach, and it tells the same story as site footprint.
Within-phase contrast
PHASE AND FOOTPRINTSelected within-phase no-results rates for single-site versus 20-plus-site studiesPHASE1 | single85.7%PHASE1 | 20+65.4%PHASE3 | single76.3%PHASE3 | 20+25.7%NA | single84.6%NA | 20+48.6%
The site-footprint advantage survives inside the major phases rather than disappearing as pure phase mix.
That makes the geography signal harder to dismiss as a compositional artifact.
Read Across Projects

Across The Series

Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.

Industry
CT.gov Industry Disclosure Gap

Industry-focused missing-results stock, sponsor backlogs, and structural sparsity inside CT.gov.

Sponsor Classes
CT.gov Sponsor-Class Hiddenness

Sponsor-class comparisons on rate, stock, and structural hiddenness rather than one flattened ranking.

Phases
CT.gov Phase Reporting Gap

Phase-by-phase disclosure gaps showing how silence changes along the development pathway.

Structural
CT.gov Structural Missingness

Field-level missingness across publication links, IPD statements, descriptions, and locations.

Visibility
CT.gov Evidence Visibility Gap

Results-plus-publication visibility states showing how many older trials are fully visible, partly visible, or ghosted.

Cohorts
CT.gov Completion Cohort Debt

Completion-era reporting debt showing how older eligible cohorts drift on no-results and ghost-protocol rates.

Conditions
CT.gov Condition Hiddenness Map

Keyword-classified therapeutic-area hiddenness mapping across common condition families.

Concentration
CT.gov Sponsor Backlog Concentration

Concentration and inequality analysis showing how much unresolved stock sits inside a thin sponsor slice.

Rule Eras
CT.gov Rule-Era Reporting Gap

Policy-era comparisons across pre-FDAAA, FDAAA, and later CT.gov completion cohorts.

PubMed Audit
CT.gov Publication Undercount Audit

Sample-based external PubMed NCT audit testing how often CT.gov no-link records hide an external paper trail.

Oncology
CT.gov Oncology Hiddenness

Oncology-specific CT.gov hiddenness showing where cancer-trial stock, phases, and sponsors still go quiet.

Cardiovascular
CT.gov Cardiovascular Hiddenness

Cardiovascular CT.gov hiddenness showing how heart and vascular studies remain quiet across major phases and sponsors.

Metabolic
CT.gov Metabolic Hiddenness

Metabolic CT.gov hiddenness across obesity, diabetes, and related trial portfolios with large late-phase and NA stock.

Size
CT.gov Enrollment-Size Gap

Enrollment-size gradients showing how older small trials remain much quieter than larger registered studies.

Purpose
CT.gov Design-Purpose Hiddenness

Primary-purpose and allocation analysis showing which trial intents remain most obscured on CT.gov.

Delay
CT.gov Completion-Delay Debt

Registration-to-completion delay analysis showing short-cycle studies carry the heaviest reporting debt.

Architecture
CT.gov Trial-Architecture Gap

Arm-count and intervention-count analysis showing simpler trial architectures are often the quietest.